Cargando…
Genetically engineered T cells for cancer immunotherapy
T cells in the immune system protect the human body from infection by pathogens and clear mutant cells through specific recognition by T cell receptors (TCRs). Cancer immunotherapy, by relying on this basic recognition method, boosts the antitumor efficacy of T cells by unleashing the inhibition of...
Autores principales: | Li, Dan, Li, Xue, Zhou, Wei-Lin, Huang, Yong, Liang, Xiao, Jiang, Lin, Yang, Xiao, Sun, Jie, Li, Zonghai, Han, Wei-Dong, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799837/ https://www.ncbi.nlm.nih.gov/pubmed/31637014 http://dx.doi.org/10.1038/s41392-019-0070-9 |
Ejemplares similares
-
Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023) -
Progress in Neoantigen Targeted Cancer Immunotherapies
por: Han, Xue-Jiao, et al.
Publicado: (2020) -
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
por: Cheng, Qinzhen, et al.
Publicado: (2023) -
Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
por: Ren, Yan-Bei, et al.
Publicado: (2018) -
Advances in Engineering Cells for Cancer Immunotherapy
por: Xu, Xiao, et al.
Publicado: (2019)